$2.80
0.062.19%
At close: Aug 21, 5:00 PM EST
$2.80
N/A
After Hours: 4:00 PM EST
Ovid Therapeutics Inc Earnings Estimates
OVIDNASDAQ
Ovid Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:OVID
Ovid Therapeutics (OVID) is scheduled to report Q3 earnings on November 11, 2026. Analysts estimate EPS of $-0.09 and quarterly revenue of $25.36K.
In the most recent quarter (Q2), Ovid Therapeutics reported EPS of $-0.08, beating estimates of $-0.1 by 0.2%. Revenue came in at $733K, exceeding the estimate of $30K by 23.43%.
Over the last 4 quarters, Ovid Therapeutics has averaged an EPS surprise of 0.51% and a revenue surprise of 7.31%.
Earnings Date
Nov 11
EPS Estimate
$-0.090
Quarterly Revenue Estimate
$25.36K
Annual Revenue
$1.58M
as of Jun 30
Ovid Therapeutics Earnings History
Analyze the earnings history of Ovid Therapeutics using advanced sorting and filters.
Ovid Therapeutics (OVID) Earnings Per Share
The chart below shows Ovid Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Ovid Therapeutics (OVID) Revenue
The chart below shows Ovid Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?
Ovid Therapeutics (OVID) is scheduled to report earnings on November 11, 2026. The last reported earnings were for reported on August 13, 2026 for Q2.
What were the latest earnings per share (EPS) for Ovid Therapeutics (NASDAQ:OVID)?
The Actual EPS was $-0.08, which beat the estimate of $-0.1.
What were Ovid Therapeutics’s (NASDAQ:OVID) revenues?
The Actual Revenue was $733K, which beat the estimate of $30K.
